Advisor Shares Investments LLC Ascendis Pharma A/S Transaction History
Advisor Shares Investments LLC
- $538 Million
- Q3 2025
A detailed history of Advisor Shares Investments LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Advisor Shares Investments LLC holds 5,558 shares of ASND stock, worth $1.1 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,558
Previous 6,518
14.73%
Holding current value
$1.1 Million
Previous $1.13 Million
1.87%
% of portfolio
0.21%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
287Shares Held
60.6MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.03 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.08 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$985 Million15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$876 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$842 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...